An Open-Label, Single-Dose, Parallel-Group Study of the Effects of Chronic Hepatic Impairment on the Safety and Pharmacokinetics of Desvenlafaxine
Baird-Bellaire, Susan, PhD, Behrle, Jessica A., MS, Parker, Vernon D., RPh, PhD, Patat, Alain, MD, Paul, Jeffrey, PhD, Nichols, Alice I., PhD
Published in Clinical therapeutics (01.06.2013)
Published in Clinical therapeutics (01.06.2013)
Get full text
Journal Article